Documents / Official release
This Defense Intelligence Reference Document, dated 7 January 2010, was prepared by the Defense Intelligence Agency's Defense Warning Office. It is one of a series of advanced technology reports produced in FY 2009 under the Advanced Aerospace Weapon System Applications program. The report reviews biomaterials used in medicine, including silicones, Teflon, biodegradable polymers, hydrogels, titanium, ceramics and tissue constructs, and applications such as stents, joints, contact lenses, drug delivery and dialysis. It concludes that most innovation lies in new ways to apply existing materials.
From the source: Release of 2026-09-18 Incident: 1/7/10, Las Vegas, Nevada. Released with redactions. This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed. This DIRD is a broad survey of biomaterials, including metals, polymers, ceramics, glasses, and composites designed to interact with living tissue, and argues that their value depends mainly on biocompatibility, reliability, and careful matching of material properties to specific medical uses. The report reviews major application areas including biosensors, implants, cardiovascular devices, contact lenses, drug delivery systems, tissue constructs, titanium devices, and dialysis membranes, emphasizing that no single biomaterial works best in every setting. Its overall conclusion is that biomaterials are already foundational to a large medical-device industry and save or improve millions of lives, but that progress tends to be slow because safety testing is stringent; as a result, most advances come from improved ways of applying established materials such as silicone, Teflon, biodegradable polymers, ceramics, and titanium in new devices and clinical settings rather than from radically new substances.
UNCLASSIFIED/ /FOR OFFICIAL USE Oiltt Biomaterials for Biosensors Implantable biosensors for the human body place some of the greatest functional demands on biomaterials. Biosensors monitor the physiologic state of tissues for medical therapeutics or for assessing human performance. Sensors for glucose, oxygen, blood pH, adrenal hormones, nervous activity, heart performance, and blood pressure monitors are all of interest. Blood biochemistry sensors are the most difficult sensors to keep functioning over time primarily because the sensor interface materials provoke low-level foreign-body reactions in t issues. These types of responses are not specifically important to implantable devices that have structural rather than sensing functions, such as heart valves, but they can completely render a biosensor for blood glucose, for example, useless after a few days. Chemically sensitive biosensor interfaces to tissue and body environments employ membranes in an effort to protect the biosensor active-sensing surface from possible body reactions. The membrane allows small molecules of interest to pass through its pores while excluding larger proteins, blood-formed elements, and cells like macrophages that would engulf the sensor. The membrane's biomaterial composition, pore size, and long-term physical integrity are critical components in the functioning of the sensor. If the biomaterial chosen retards the adhesion of proteins and does not provoke a biological response, then this improves sensor longevity. Figure 3 shows some representative biomembranes. No one biomaterial is best for all sensor applications, primarily because different biomaterials behave differently relative to the substance being sensed. Membranes that pass glucose, for example, may not pass oxygen that is needed for a sensor to function. Membrane biofouling starts immediately upon contact of the sensor with the body cells. Proteins and other biological components adhere to the sensor surface, and in some cases, impregnate the pores of the material. This process retards diffusion of the molecules of interest to the sensor surface and either slows the sensor's response to changes in concentration or reduces the overall response to the point where the sensor falls out of calibration. The design of sensor membrane materials has been found to be critically dependent on subtle features of the membrane's chemistry, material thickness, and porosity, as well as, more generally, where in the human body the sensor is located. The blood stream is UNCLASSIFIED/ /fiiOA OFFI&IAk WSE 8rtt'f Figure 3. Biomaterials Such as Polycarbonates, Cellulose, and Silicones Used in Membranes for Sensors, Dialyzers, and Oxygenators 1
Not linked to a story yet.
Official release, from the pursue collection. The PDF is mirrored here; the original link is above. 32 pages are in the text index: search them above, or from the library's search.